Skip to main content
. Author manuscript; available in PMC: 2012 Oct 12.
Published in final edited form as: Chem Rev. 2011 Sep 12;111(10):6130–6185. doi: 10.1021/cr200085w

Table 15.

Group GIV Cytosolic Phospholipase A2s (cPLA2)

Subgroup Initial/common
sources
Residues
/Molecular
Mass
Domain Activation
Factor
Substrate Activity Post
Translational
Modification
Human
chromosome
Swiss-
Prot
GIVA
(cPLA2α)
Human
macrophage–like
U937 cells/
platelets/RAW
264.7/rat kidney,

Ubiquitous
749/

85 Kda
C2

α/ β
hydrolase

Cap
Ca2+

PIP2

C1P
Phosphor
y-lation
PC, PE,
PI

High sn-
2AA
specificity
PLA2, PLA1,

Lyso-PLA

transacylase
Phosphorylation 1q25 P47712
GIVB

(cPLA2β)
Human pancreas/
liver/heart/brain,
Ubiquitous
1012

/100−
114
Kda
JmjC insert
C2

α/ β

hydrolase
Ca2+ PC, PE

No sn-2
specificity
PLA1, PLA2,

Lyso-PLA

transacylase
15q11.2
-

q21.3
AAD321
35
GIVC
(cPLA2γ)
Human heart
/skeletal muscle
541/

61 Kda
α/β
hydrolase
PC

Low sn-2
AA
specificity
PLA1, PLA2

Lyso-PLA
Farnesylation 19q13.3 AAC328
23
GIVD
(cPLA2δ)
Murine placenta 818/
91 Kda
C2
α/ β
hydrolase
Ca2+ PC, PE PLA1, PLA2
Lyso-PLA
15q15.1 Q86XP0
.2
GIVE
(cPLA2ε)
Murine heart
/skeletal
muscle/testis/thyroid
838/

95 Kda
C2

α/ β
hydrolase
Ca2+ PC, PE PLA1,PLA2
Lyso-PLA
15q15.1 Q3MJ16
.2
GIVF
(cPLA2ζ)
Murine thyroid
/stomach
849/

95 Kda
C2

α/ β
hydrolase
Ca2+ PC, PE PLA1,PLA2

Lyso-PLA
15q15.1 Q68DD2
.2